Literature DB >> 15308282

The newer fluoroquinolones.

Judith A O'Donnell1, Steven P Gelone.   

Abstract

This article discusses the newer fluoroquinolones in detail with respect to their pharmacokinetics, pharmacodynamics, safety, and spectrum of in vitro activity. The newer agents are compared and contrasted with the older ones, particularly ciprofloxacin. Efficacy of the newer fluoroquinolones when compared with antimicrobial agents in other classes is also presented in detail. Appropriate use of the newer fluoroquinolones is addressed, including their ever expanding role in the treatment of both upper and lower respiratory tract infections and skin and soft tissue infection. Available data on the use of the newer fluoroquinolones in the management of genitourinary tract infections, gastrointestinal infections, and osteomyelitis are also discussed.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15308282     DOI： 10.1016/j.idc.2004.04.011

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN： 0891-5520            Impact factor:   5.982


  5 in total

1.  Fluoroquinolone susceptibility in Mycobacterium tuberculosis after pre-diagnosis exposure to older- versus newer-generation fluoroquinolones.

Authors:  Yuri F van der Heijden; Fernanda Maruri; Amondrea Blackman; Ed Mitchel; Aihua Bian; Ayumi K Shintani; Svetlana Eden; Jon V Warkentin; Timothy R Sterling
Journal:  Int J Antimicrob Agents       Date:  2013-06-24       Impact factor: 5.283

2.  Levofloxacin-induced Achilles tendinitis in a young adult in the absence of predisposing conditions.

Authors:  Areum Durey; Yong Soo Baek; Jin Seok Park; Kwangsoo Lee; Jeong-Seon Ryu; Jin-Soo Lee; Moon-Hyun Cheong
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

3.  Cumulative clinical experience from over a decade of use of levofloxacin in urinary tract infections: critical appraisal and role in therapy.

Authors:  Larry M Bush; Fredy Chaparro-Rojas; Victor Okeh; Joseph Etienne
Journal:  Infect Drug Resist       Date:  2011-10-18       Impact factor: 4.003

4.  Synthesis of 1,2,3-Triazolo[4,5-h]quinolone Derivatives with Novel Anti-Microbial Properties against Metronidazole Resistant Helicobacter pylori.

Authors:  Mohammad Abu-Sini; Amal Mayyas; Nehaya Al-Karablieh; Rula Darwish; Yusuf Al-Hiari; Talal Aburjai; Shereen Arabiyat; Luay Abu-Qatouseh
Journal:  Molecules       Date:  2017-05-20       Impact factor: 4.411

5.  New Pharmacokinetic and Microbiological Prediction Equations to Be Used as Models for the Search of Antibacterial Drugs.

Authors:  Jose I Bueso-Bordils; Gerardo M Antón-Fos; Antonio Falcó; Maria J Duart; Rafael Martín-Algarra; Pedro A Alemán-López
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.